Study reveals impact of lantibiotic preservatives on gut microbiome

Boehringer In­gel­heim is the lat­est phar­ma­ceu­ti­cal com­pa­ny to sue the fed­er­al gov­ern­ment over the In­fla­tion Re­duc­tion Act in a fight some drug pric­ing ex­perts say

Immune checkpoint inhibitors are at the forefront of treatment options for melanoma, leading to durable disease control and long-term survivors. But as a result, these